scPharmaceuticals (SCPH) Competitors $5.52 +0.01 (+0.18%) Closing price 04:00 PM EasternExtended Trading$5.52 0.00 (-0.09%) As of 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SCPH vs. PRAX, CRMD, CRON, NUVB, VERV, VALN, MLYS, ATAI, IOVA, and UPBShould you be buying scPharmaceuticals stock or one of its competitors? The main competitors of scPharmaceuticals include Praxis Precision Medicines (PRAX), CorMedix (CRMD), Cronos Group (CRON), Nuvation Bio (NUVB), Verve Therapeutics (VERV), Valneva (VALN), Mineralys Therapeutics (MLYS), atai Life Sciences (ATAI), Iovance Biotherapeutics (IOVA), and Upstream Bio (UPB). These companies are all part of the "pharmaceutical products" industry. scPharmaceuticals vs. Its Competitors Praxis Precision Medicines CorMedix Cronos Group Nuvation Bio Verve Therapeutics Valneva Mineralys Therapeutics atai Life Sciences Iovance Biotherapeutics Upstream Bio scPharmaceuticals (NASDAQ:SCPH) and Praxis Precision Medicines (NASDAQ:PRAX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends. Do institutionals & insiders hold more shares of SCPH or PRAX? 89.5% of scPharmaceuticals shares are held by institutional investors. Comparatively, 67.8% of Praxis Precision Medicines shares are held by institutional investors. 4.8% of scPharmaceuticals shares are held by insiders. Comparatively, 2.7% of Praxis Precision Medicines shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, SCPH or PRAX? scPharmaceuticals has higher revenue and earnings than Praxis Precision Medicines. Praxis Precision Medicines is trading at a lower price-to-earnings ratio than scPharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioscPharmaceuticals$36.33M8.10-$85.15M-$1.81-3.05Praxis Precision Medicines$8.55M114.61-$182.82M-$12.29-3.79 Which has more volatility & risk, SCPH or PRAX? scPharmaceuticals has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500. Comparatively, Praxis Precision Medicines has a beta of 2.61, suggesting that its share price is 161% more volatile than the S&P 500. Is SCPH or PRAX more profitable? scPharmaceuticals has a net margin of -183.55% compared to Praxis Precision Medicines' net margin of -2,137.48%. Praxis Precision Medicines' return on equity of -60.07% beat scPharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets scPharmaceuticals-183.55% -1,647.86% -71.76% Praxis Precision Medicines -2,137.48%-60.07%-54.84% Do analysts rate SCPH or PRAX? scPharmaceuticals presently has a consensus price target of $7.78, suggesting a potential upside of 41.00%. Praxis Precision Medicines has a consensus price target of $85.88, suggesting a potential upside of 84.48%. Given Praxis Precision Medicines' stronger consensus rating and higher probable upside, analysts plainly believe Praxis Precision Medicines is more favorable than scPharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score scPharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Praxis Precision Medicines 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.78 Does the media prefer SCPH or PRAX? In the previous week, Praxis Precision Medicines had 6 more articles in the media than scPharmaceuticals. MarketBeat recorded 12 mentions for Praxis Precision Medicines and 6 mentions for scPharmaceuticals. Praxis Precision Medicines' average media sentiment score of 1.21 beat scPharmaceuticals' score of 0.72 indicating that Praxis Precision Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment scPharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Praxis Precision Medicines 7 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryPraxis Precision Medicines beats scPharmaceuticals on 9 of the 16 factors compared between the two stocks. Get scPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCPH vs. The Competition Export to ExcelMetricscPharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$293.14M$3.12B$5.77B$9.77BDividend YieldN/A2.28%6.66%4.49%P/E Ratio-3.0521.1082.3726.60Price / Sales8.10408.88536.82175.38Price / CashN/A43.5325.7028.92Price / Book-13.808.1310.646.56Net Income-$85.15M-$53.35M$3.28B$266.04M7 Day PerformanceN/A0.45%-0.08%-0.58%1 Month Performance6.77%9.94%10.36%6.24%1 Year Performance11.52%11.73%49.00%22.21% scPharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCPHscPharmaceuticals3.9033 of 5 stars$5.52+0.2%$7.78+41.0%+8.3%$293.14M$36.33M-3.0530Short Interest ↑PRAXPraxis Precision Medicines2.8789 of 5 stars$46.94-3.8%$85.88+82.9%-15.4%$1.03B$8.55M-3.82110Analyst ForecastCRMDCorMedix3.4199 of 5 stars$13.73+0.3%$16.71+21.7%+134.6%$1.02B$43.47M18.3130News CoveragePositive NewsShort Interest ↑CRONCronos Group0.839 of 5 stars$2.60-0.2%N/A+10.6%$995.90M$117.61M51.90450NUVBNuvation Bio2.2616 of 5 stars$2.88-0.7%$7.33+154.6%-8.5%$992.59M$7.87M-4.5760News CoveragePositive NewsVERVVerve Therapeutics2.1288 of 5 stars$11.13flat$14.57+30.9%N/A$992.13M$32.33M-5.27110VALNValneva1.9838 of 5 stars$9.43-19.0%$16.00+69.7%+17.9%$990.49M$183.52M-9.62700Short Interest ↑Gap DownHigh Trading VolumeMLYSMineralys Therapeutics2.5924 of 5 stars$14.74-1.0%$32.25+118.8%+132.6%$986.80MN/A-4.1428Trending NewsAnalyst ForecastGap DownATAIatai Life Sciences3.5053 of 5 stars$4.74+3.7%$11.25+137.3%+253.1%$979.53M$310K-6.8780Gap UpHigh Trading VolumeIOVAIovance Biotherapeutics4.2927 of 5 stars$2.53-5.9%$11.90+370.4%-81.2%$973.39M$164.07M-2.06500Positive NewsUPBUpstream Bio2.2605 of 5 stars$16.73-5.1%$56.50+237.7%N/A$950.42M$2.37M0.0038News CoveragePositive NewsGap Up Related Companies and Tools Related Companies Praxis Precision Medicines Alternatives CorMedix Alternatives Cronos Group Alternatives Nuvation Bio Alternatives Verve Therapeutics Alternatives Valneva Alternatives Mineralys Therapeutics Alternatives atai Life Sciences Alternatives Iovance Biotherapeutics Alternatives Upstream Bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCPH) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding scPharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share scPharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
